Skeletal myoblasts for cardiac repair

Regenerative Medicine

Volumn 5, Issue 6, 2010, Pages 919-932

  Durrani, Shazia ^a   Konoplyannikov, Mikhail ^a   Ashraf, Muhammad ^a   Haider, Khawaja Husnain ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

heart; myoblast; myocardium; stem cell

Indexed keywords

ANGIOPOIETIN 1; CARDIOTROPHIN 1; FIBROBLAST GROWTH FACTOR; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1; MICRORNA; NERVE CELL ADHESION MOLECULE; RECOMBINANT GROWTH FACTOR; RELAXIN; SCATTER FACTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; VASCULOTROPIN;

ACUTE HEART INFARCTION; CARDIOMYOPATHY; CELL PROTECTION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; EXCITATION CONTRACTION COUPLING; EXPERIMENTAL ANIMAL; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; MYOBLAST; MYOCARDIAL DISEASE; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE STRESS; PACEMAKER; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE ABILITY; REVIEW; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MYOBLASTS, SKELETAL; MYOCARDIUM; REGENERATION; STEM CELL TRANSPLANTATION; WOUND HEALING;

EID: 78649360438     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.10.65     Document Type: Review

References (134)

1. Cleland JG, McGowan J: Heart failure due to ischaemic heart disease: epidemiology, pathophysiology and progression. J. Cardiovasc. Pharmacol. 33(Suppl. 3), S17-S29 (1999).
2. Frangogiannis NG: The immune system and cardiac repair. Pharmacol. Res. 58, 88-111 (2008).
3. Haqqani HM, Mond HG: The implantable cardioverter-defbrillator lead: principles, progress, and promises. Pacing Clin. Electrophysiol. 32, 1336-1353 (2009).
4. Alba AC, Delgado DH: The future is here: ventricular assist devices for the failing heart. Expert Rev. Cardiovasc. Ther. 7, 1067-1077 (2009).
5. Soonpaa MH, Field LJ: Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am. J. Physiol. 272, H220-H226 (1997).
6. Rubart M, Field LJ: Cardiac regeneration: repopulating the heart. Annu. Rev. Physiol. 68, 29-49 (2006).
7. Bergmann O, Bhardwaj RD, Bernard S et al.: Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 (2009).
8. Hassink RJ, Pasumarthi KB, Nakajima H et al.: Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc. Res. 78, 18-25 (2008).
9. Anversa P, Leri A, Kajstura J, Nadal-Ginard B: Myocyte growth and cardiac repair. J. Mol. Cell Cardiol. 34, 91-105 (2002).
10. Nadal-Ginard B, Kajstura J, Leri A, Anversa P: Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 92, 139-150 (2003).
11. Anversa P, Kajstura J, Leri A, Bolli R: Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113, 1451-1463 (2006).
12. Beltrami AP, Barlucchi L, Torella D et al.: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776 (2003).
13. Anversa P, Leri A, Kajstura J: Cardiac regeneration. J. Am. Coll. Cardiol. 47, 1769-1776 (2006).
14. Bearzi C, Leri A, Lo Monaco F et al.: Identifcation of a coronary vascular progenitor cell in the human heart. Proc. Natl Acad. Sci. USA 106(37), 15885-15890 (2009).
15. Rota M, Padin-Iruegas ME, Misao Y et al.: Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ. Res. 103, 107-116 (2008).
16. Dawn B, Stein AB, Urbanek K et al.: Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl Acad. Sci. USA 102, 3766-3771 (2005).
17. Matsuura K, Honda A, Nagai T et al.: Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J. Clin. Invest. 119, 2204-2217 (2009).
18. Leri A, Hosoda T, Rota M, Kajstura J, Anversa P: Myocardial regeneration by exogenous and endogenous progenitor cells. Drug Discov. Today Dis. Mech. 4, 197-203 (2007).
19. Kajstura J, Rota M, Whang B et al.: Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. 96, 127-137 (2005).
20. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P: Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. NY Acad. Sci. 938, 221-229 (2001).
21. Kudo M, Wang Y, Wani MA et al.: Implantation of bone marrow stem cells reduces the infarction and fbrosis in ischemic mouse heart. J. Mol. Cell Cardiol. 35, 1113-1119 (2003).
22. Haider H, Ye L, Jiang S et al.: Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J. Mol. Med. 82, 539-549 (2004).
23. Nelson TJ, Martinez-Fernandez A, Yamada S et al.: Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120, 408-416 (2009).
24. Siu CW, Moore JC, Li RA: Human embryonic stem cell-derived cardiomyocytes for heart therapies. Cardiovasc. Hematol. Disord. Drug Targets 7, 145-152 (2007).
25. Crisostomo PR, Abarbanell AM, Wang M et al.: Embryonic stem cells attenuate myocardial dysfunction and infammation after surgical global ischemia via paracrine actions. Am. J. Physiol. Heart Circ. Physiol. 295, H1726-H1735 (2008).
26. Martinez-Fernandez A, Nelson TJ, Yamada S et al.: iPS programmed without c-MYC yield profcient cardiogenesis for functional heart chimerism. Circ. Res. 105, 648-656 (2009).
27. Halbach M, Pfannkuche K, Pillekamp F et al.: Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation. Circ. Res. 101, 484-492 (2007).
28. Ye L, Haider H, Jiang S et al.: Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model. Eur. J. Heart Fail. 7, 945-952 (2005).
29. Menasche P, Alferi O, Janssens S et al.: The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117, 1189-1200 (2008).
30. Ye L, Haider H, Tan R et al.: Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair. Biomaterials 29, 2125-2137 (2008).
31. Ye L, Haider H, Tan R et al.: Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation 116, I113-I120 (2007).
32. Khan M, Kutala VK, Vikram DS et al.: Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. Am. J. Physiol. Heart Circ. Physiol. 293, H2129-H2139 (2007).
33. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 126, 663-676 (2006).
34. Yamanaka S: Strategies and new developments in the generation of patient-specifc pluripotent stem cells. Cell Stem Cell 21, 39-49 (2007).
35. Freund C, Mummery CL: Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J. Cell Biochem. 107, 592-599 (2009).
36. Mauritz C, Schwanke K, Reppel M et al.: Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507-517 (2008).
37. Mias C, Lairez O, Trouche E et al.: Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fbroblasts and reduce cardiac ventricular fbrosis after myocardial infarction. Stem Cells 27(11), 2734-2743 (2009).
38. Schuleri KH, Feigenbaum GS, Centola M et al.: Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur. Heart J. 30(22), 2722-2732 (2009).
39. Hoashi T, Matsumiya G, Miyagawa S et al.: Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. J. Thorac. Cardiovasc. Surg. 138, 460-467 (2009).
40. Ghostine S, Carrion C, Souza LC et al.: Long-term effcacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106, I131-I136 (2002).
41. Gavira JJ, Herreros J, Perez A et al.: Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J. Thorac. Cardiovasc. Surg. 131, 799-804 (2006).
42. Ince H, Petzsch M, Rehders TC et al.: Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J. Endovasc. Ther. 11, 695-704 (2004).
43. Menasche P: Skeletal myoblasts as a therapeutic agent. Prog. Cardiovasc. Dis. 50, 7-17 (2007).
44. Haider H, Tan AC, Aziz S, Chachques JC, Sim EK: Myoblast transplantation for cardiac repair: a clinical perspective. Mol. Ther. 9, 14-23 (2004).
45. Al Attar N, Carrion C, Ghostine S et al.: Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc. Res. 58, 142-148 (2003).
46. Taylor DA, Atkins BZ, Hungspreugs P et al.: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4, 929-933 (1998).
47. McCue JD, Swingen C, Feldberg T et al.: The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. J. Heart Lung Transplant 27, 116-123 (2008).
48. Brasselet C, Morichetti MC, Messas E et al.: Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium. Eur. Heart J. 26, 1551-1556 (2005).
49. Hata H, Matsumiya G, Miyagawa S et al.: Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J. Thorac. Cardiovasc. Surg. 132, 918-924 (2006).
50. He KL, Yi GH, Sherman W et al.: Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J. Heart Lung Transplant. 24, 1940-1949 (2005).
51. Ye L, Haider H, Jiang S et al.: Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1. Eur. J. Heart Fail. 9, 15-22 (2007).
52. Chazaud B, Hittinger L, Sonnet C et al.: Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage. Cardiovasc. Res. 58, 444-450 (2003).
53. Zhang Z, van den Bos EJ, Wielopolski PA et al.: High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner. MAGMA 17, 201-209 (2004).
54. Atkins BZ, Hueman MT, Meuchel J et al.: Cellular cardiomyoplasty improves diastolic properties of injured heart. J. Surg. Res. 85, 234-242 (1999).
55. Marelli D, Desrosiers C, el-Alfy M, Kao RL, Chiu RC: Cell transplantation for myocardial repair: an experimental approach. Cell Transplant. 1, 383-390 (1992).
56. Reinecke H, Murry CE: Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc. Pathol. 9, 337-344 (2000).
57. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD: Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest. 98, 2512-2523 (1996).
58. Reinecke H, MacDonald GH, Hauschka SD, Murry CE: Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J. Cell Biol. 149, 731-740 (2000).
59. Peterson JM, Pizza FX: Cytokines derived from cultured skeletal muscle cells after mechanical strain promote neutrophil chemotaxis in vitro. J. Appl. Physiol. 106, 130-137 (2009).
60. Tatsumi R, Hattori A, Ikeuchi Y, Anderson JE, Allen RE: Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol. Biol. Cell 13, 2909-2918 (2002).
61. Pouzet B, Ghostine S, Vilquin JT et al.: Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 104, I223-I228 (2001).
62. Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M: Ex vivo delivered stromal cell-derived factor-1a promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J. Mol. Cell Cardiol. 42, 792-803 (2007).
63. Murtuza B, Suzuki K, Bou-Gharios G et al.: Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc. Natl Acad. Sci. USA 101, 4216-4221 (2004).
64. Suzuki K, Murtuza B, Smolenski RT et al.: Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104, I207-I212 (2001).
65. Aharinejad S, Abraham D, Paulus P et al.: Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc. Res. 79, 395-404 (2008).
66. Toh R, Kawashima S, Kawai M et al.: Transplantation of cardiotrophin-1-expressing myoblasts to the left ventricular wall alleviates the transition from compensatory hypertrophy to congestive heart failure in Dahl salt-sensitive hypertensive rats. J. Am. Coll. Cardiol. 43, 2337-2347 (2004).
67. Formigli L, Francini F, Nistri S et al.: Skeletal myoblasts overexpressing relaxin improve differentiation and communication of primary murine cardiomyocyte cell cultures. J. Mol. Cell. Cardiol. 47, 335-345 (2009).
68. Bonacchi M, Nistri S, Nanni C et al.: Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy. J. Cell Mol. Med. 13, 3437-3448 (2009).
69. Kim CK, Haider KH, Lim SJ: Gene medicine: a new feld of molecular medicine. Arch Pharm Res. 24, 1-15 (2001).
70. Ye L, Haider HK, Esa WB et al.: Liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischemic limb disease. J. Cell Mol. Med. 14(1-2), 323-336 (2010).
71. Chanseaume S, Azarnoush K, Maurel A et al.: Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium? Interact. Cardiovasc. Thorac. Surg. 6, 293-297 (2007).
72. Lafreniere JF, Mills P, Tremblay JP, El Fahime E: Growth factors improve the in vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity. Transplantation 77, 1741-1747 (2004).
73. Kim HW, Haider HK, Jiang S, Ashraf M: Ischemic preconditioning augments survival of stem cells via MIR-210 expression by targeting caspase-8 associated protein 2. J. Biol. Chem. 284(48), 33161-33168 (2009).
74. Niagara MI, Haider H, Jiang S, Ashraf M: Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ. Res. 100, 545-555 (2007).
75. Ott HC, Kroess R, Bonaros N et al.: Intramyocardial microdepot injection increases the effcacy of skeletal myoblast transplantation. Eur. J. Cardiothorac. Surg. 27, 1017-1021 (2005).
76. Menasche P, Hagege AA, Scorsin M et al.: Myoblast transplantation for heart failure. Lancet 357, 279-280 (2001).
77. Hagege AA, Carrion C, Menasche P et al.: Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361, 491-492 (2003).
78. Menasche P, Hagege AA, Vilquin JT et al.: Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41, 1078-1083 (2003).
79. Pagani FD, DerSimonian H, Zawadzka A et al.: Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological ana lysis of cell survival and differentiation. J. Am. Coll. Cardiol. 41, 879-888 (2003).
80. Dib N, McCarthy P, Campbell A et al.: Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant. 14, 11-19 (2005). (Pubitemid 40387674)
81. Herreros J, Prosper F, Perez A et al.: Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J. 24, 2012-2020 (2003).
82. Siminiak T, Kalawski R, Fiszer D et al.: Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am. Heart J. 148, 531-537 (2004).
83. Dib N, Campbell A, Jacoby DB et al.: Safety and feasibility of percutaneous autologous skeletal myoblast transplantation in the coil-infarcted swine myocardium. J. Pharmacol. Toxicol. Methods 54, 71-77 (2006).
84. Siminiak T, Fiszer D, Jerzykowska O et al.: Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur. Heart J. 26, 1188-1195 (2005).
85. Dib N, Dinsmore J, Lababidi Z et al.: One-year follow-up of feasibility and safety of the frst U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc. Interv. 2, 9-16 (2009).
86. Larose E, Proulx G, Voisine P et al.: Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study. Catheter. Cardiovasc. Interv. 75, 120-127 (2010).
87. Smits PC, van Geuns RJ, Poldermans D et al.: Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 42, 2063-2069 (2003).
88. Chachques JC, Herreros J, Trainini J et al.: Autologous human serum for cell culture avoids the implantation of cardioverter-defbrillators in cellular cardiomyoplasty. Int. J. Cardiol. 95(Suppl. 1), S29-S33 (2004).
89. Ferreira-Cornwell MC, Luo Y, Narula N, Lenox JM, Lieberman M, Radice GL: Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J. Cell Sci. 115, 1623-1634 (2002).
90. Formigli L, Francini F, Tani A et al.: Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment. Am. J. Physiol. Cell Physiol. 288, C795-C804 (2008).
91. Suzuki K, Brand NJ, Allen S et al.: Overexpression of connexin 43 in skeletal myoblasts: relevance to cell transplantation to the heart. J. Thorac. Cardiovasc. Surg. 122, 759-766 (2001).
92. Roell W, Lewalter T, Sasse P et al.: Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 450, 819-824 (2007).
93. Fernandes S, van Rijen HV, Forest V et al.: Cardiac cell therapy: overexpression of connexin 43 in skeletal myoblasts and prevention of ventricular arrhythmias. J. Cell Mol. Med. 13(9B), 3703-3712 (2009).
94. Garcia J, Tanabe T, Beam KG: Relationship of calcium transients to calcium currents and charge movements in myotubes expressing skeletal and cardiac dihydropyridine receptors. J. Gen. Physiol. 103, 125-147 (1994).
95. Abraham MR, Hare JM: Is skeletal myoblast transplantation proarrhythmic? The jury is still out. Heart Rhythm 3, 462-463 (2006).
96. Fouts K, Fernandes B, Mal N, Liu J, Laurita KR: Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm 3, 452-461 (2006).
97. Eisen HJ: Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med. 5, 520-521 (2008).
98. Suzuki K, Murtuza B, Beauchamp JR et al.: Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J. 18, 1153-1155 (2004). (Pubitemid 39561554)
99. Haider H, Ashraf M: Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J. Mol. Cell Cardiol. 45, 554-566 (2008).
100. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M: Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc. Res. 77, 134-142 (2008).
101. El Fahime E, Bouchentouf M, Benabdallah BF et al.: Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success. Biochem. Cell Biol. 81, 81-90 (2003).
102. Jiang S, Kh Haider H, Ahmed RP, Idris NM, Salim A, Ashraf M: Transcriptional profling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium. J. Mol. Cell Cardiol. 44, 582-596 (2008).
103. Kan CD, Li SH, Weisel RD, Zhang S, Li RK: Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation. J. Am. Coll. Cardiol. 50, 1086-1092 (2007).
104. Haider H, Jiang SJ, Ye L, Aziz S, Law PK, Sim EK: Effectiveness of transient immunosuppression using cyclosporine for xenomyoblast transplantation for cardiac repair. Transplant Proc. 36, 232-235 (2004).
105. Law PK, Fang G, Chua F, Kakuchaya T, Bockeria LA: First-in-man myoblast allografts for heart degeneration. Int. J. Med. Implants Devices 1, 100-155 (2003).
106. Conboy IM, Conboy MJ, Smythe GM, Rando TA: Notch-mediated restoration of regenerative potential to aged muscle. Science 302, 1575-1577 (2003).
107. Chen JF, Mandel EM, Thomson JM et al.: The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233 (2006).
108. Foshay KM, Gallicano GI: Small RNAs, big potential: the role of microRNAs in stem cell function. Curr. Stem Cell Res. Ther. 2, 264-271 (2007).
109. Hime GR, Somers WG: Micro-RNA mediated regulation of proliferation, self-renewal and differentiation of mammalian stem cells. Cell Adh. Migr. 3(4), 425-432 (2009).
110. Callis TE, Chen JF, Wang DZ: MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol. 26, 219-225 (2007).
111. Chen JF, Callis TE, Wang DZ: MicroRNAs and muscle disorders. J. Cell Sci. 122, 13-20 (2009).
112. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A: Muscle-specifc microRNA miR-206 promotes muscle differentiation. J. Cell Biol. 174, 677-687 (2006).
113. Anderson C, Catoe H, Werner R: MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res. 34, 5863-5871 (2006).
114. Pouzet B, Vilquin JT, Hagege AA et al.: Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized? Circulation 102, III210-III215 (2000).
115. Fukushima S, Coppen SR, Lee J et al.: Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS ONE 3, e3071 (2008).
116. Skuk D, Goulet M, Tremblay JP: Use of repeating dispensers to increase the effciency of the intramuscular myogenic cell injection procedure. Cell Transplant. 15, 659-663 (2006).
117. Suzuki K, Murtuza B, Fukushima S et al.: Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and infuence on cardiac function. Circulation 110, II225-II230 (2004).
118. Suzuki K, Brand NJ, Smolenski RT, Jayakumar J, Murtuza B, Yacoub MH: Development of a novel method for cell transplantation through the coronary artery. Circulation 102, III359-III364 (2000).
119. Perin EC, Dohmann HF, Borojevic R et al.: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107, 2294-2302 (2003).
120. Gavira JJ, Perez-Ilzarbe M, Abizanda G et al.: A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Cardiovasc. Res. 71, 744-753 (2006).
121. Gavira JJ, Nasarre E, Abizanda G et al.: Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction. Eur. Heart J. 31(8), 1013-1021 (2009).
122. Premaratne GU, Tambara K, Fujita M et al.: Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ. J. 70, 1184-1189 (2006).
123. Martens TP, Godier AF, Parks JJ et al.: Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant. 18, 297-304 (2009).
124. Hamdi H, Furuta A, Bellamy V et al.: Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann. Thorac. Surg. 87, 1196-1203 (2009).
125. Giraud MN, Ayuni E, Cook S, Siepe M, Carrel T P, Tevaearai HT: Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction. Artif. Organs 32, 692-700 (2008).
126. Sherman W, He KL, Yi GH et al.: Myoblast transfer in ischemic heart failure: effects on rhythm stability. Cell Transplant. 18, 333-341 (2009).
127. Ye L, Haider H, Sim EK: Adult stem cells for cardiac repair: a choice between skeletal myoblasts and bone marrow stem cells. Exp. Biol. Med. (Maywood) 231, 8-19 (2006).
128. Lafreniere JF, Caron MC, Skuk D, Goulet M, Cheikh AR, Tremblay JP: Growth factor co-injection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplant. 18(7), 719-730 (2009).
129. Mikhail Konoplyannikov M, Jiang S, Ahmed R, Ashraf M, Haider HK: Reversal of ischemic cardiomyopathy using reprogrammed skeletal myoblasts overexpressing multiple therapeutic growth factor genes. Circulation 120, S773-S774 (2009).
130. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA: Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144, 1113-1122 (1999).
131. Winitsky SO, Gopal TV, Hassanzadeh S et al.: Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol. 3, e87 (2005).
132. Okada M, Payne TR, Zheng B et al.: Myogenic endothelial cells purifed from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J. Am. Coll. Cardiol. 52, 1869-1880 (2008).
133. Sim EK, Haider HK, Aziz S, Ooi OC, Law PK: Myoblast transplantation on the beating heart. Int. Surg. 90, 148-150 (2005).
134. Biagini E, Valgimigli M, Smits PC et al.: Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure. Eur. J. Heart Fail. 8, 641-648 (2006).